Total Funding
1
Total FundingPrivate Equity raised
Growth Score
pts
Heat Score
-42 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
2190548
Gemphire Therapeutics manufactures and markets Gemcabene, an LDL cholesterol-lowering medication.
About the Company
Gemphire Therapeutics manufactures and markets Gemcabene, an LDL cholesterol-lowering medication. It is a clinical-stage biopharmaceutical company that is committed to helping patients with cardiometabolic disorders, including dyslipidemia and NASH.
The company was founded in 2014 and is based in Northville, Michigan.
